Você está em:Start > Publications > View > Long-Term Efficacy, Tolerability, and Renal Safety of Atazanavir/Ritonavirbased Antiretroviral Therapy in a Cohort of Treatment-Naïve Patients with HIV-1 Infection: the REMAIN Study
Long-Term Efficacy, Tolerability, and Renal Safety of Atazanavir/Ritonavirbased Antiretroviral Therapy in a Cohort of Treatment-Naïve Patients with HIV-1 Infection: the REMAIN Study
Long-Term Efficacy, Tolerability, and Renal Safety of Atazanavir/Ritonavirbased Antiretroviral Therapy in a Cohort of Treatment-Naïve Patients with HIV-1 Infection: the REMAIN Study